Please use this identifier to cite or link to this item:
Scopus Web of Science® Altmetric
Full metadata record
DC FieldValueLanguage
dc.contributor.authorFaull, R.en
dc.identifier.citationSeminars in Dialysis, 2007; 20(3):191-194en
dc.descriptionThe definitive version is available at www.blackwell-synergy.comen
dc.description.abstractThe linkage between bone parameters (calcium, phosphate, parathyroid hormone) and cardiovascular death in dialysis patients has led to a major resurgence in interest in this area of nephrological practice. Two major groups have recently published extensive guidelines for clinical practice in this area—the National Kidney Foundation's Kidney Disease Outcomes and Quality Initiative from the United States, and the Caring for Australasians with Renal Impairment group from Australia and New Zealand. There are some important differences in their recommendations, which reflect variations in local clinical practice, reimbursement systems, and interpretation of the medical literature. Two areas of divergence are highlighted in this editorial—use of vitamin D and its analogs, and use of phosphate binders. Readers of guidelines such as these need to be careful to interpret such recommendations in the context of the realities of their local clinical practice and availability of therapies.en
dc.publisherBlackwell Publishing Incen
dc.subjectHumans; Bone Diseases, Metabolic; Kidney Diseases; Calcinosis; Hyperparathyroidism; Calcitriol; Ergocalciferols; Chelating Agents; Renal Dialysis; Administration, Oral; Infusions, Intravenous; Internationality; Bone Density Conservation Agents; Practice Guidelines as Topicen
dc.titleManaging bone parameters in dialysis patients: International guideline conflictsen
dc.typeJournal articleen
pubs.library.collectionMedicine publicationsen
Appears in Collections:Medicine publications

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.